홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

인카드로닉

Incadronic Acid

HCID 3699
노트반응
기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
124351-85-5
표준 SMILES
O=P(O)(O)C(NC1CCCCCC1)P(=O)(O)O
InChIKey
LWRDQHOZTAOILO-UHFFFAOYSA-N
분자식
C8H19NO6P2
평균 분자량
287.19 g/mol
단동위원소 질량
287.06876132

개요

Incadronic acid is a 1,1-bis(phosphonic acid).

이름 및 식별자

우선 이름
Incadronic Acid
IUPAC
[(cycloheptylamino)-phosphonomethyl]phosphonic acid
현지명
인카드로닉
영어명
Incadronic
분자식
C8H19NO6P2
분자량
287.19

이름 및 동의어

Incadronic acid124351-85-5((Cycloheptylamino)methylene)diphosphonic acidCimadronic acidIncadronic acid [INN]acido incadronicoacide incadroniqueNSC-723271UNII-G5C4M8847EG5C4M8847EIncadronic acid (INN)INCADRONIC ACID [MI]
이름 더 보기
인카드로닉Incadronic((cycloheptylamino)methylene)bis(phosphonic acid)[(cycloheptylamino)-phosphonomethyl]phosphonic acidPhosphonic acid, P,P'-[(cycloheptylamino)methylene]bis-
INCADRONIC ACID [MART.]INCADRONIC ACID [WHO-DD]DTXSID90154283[(cycloheptylamino)(phosphono)methyl]phosphonic acidNSC 723271INCADRONIC ACID (MART.)((cycloheptylamino)(phosphono)methyl)phosphonic acidacidum incadronicum

데이터베이스 식별자

CAS
124351-85-5
PubChem CID
3699
DTXSID
DTXSID90154283
ChEMBL
CHEMBL53950
ChEBI
CHEBI:135189
UNII
G5C4M8847E

물성

구조 계산 물성

XLogP
-3.5
극성 표면적
127 Ų
수소 결합 공여자 수
5
수소 결합 수용자 수
7
회전 가능 결합 수
4
무거운 원자 수
17
형식 전하
0
복잡도
307

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15

물리화학적 성질

녹는점
232 · 232-233°
끓는 점
564.2 · 564.2±60.0 °C(Predicted)
밀도
1.48 · 1.48±0.1 g/cm3(Predicted)
저장 조건
2 · 2-8°C
용해도
물(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
0.61 · 0.61±0.10(Predicted)
물리적 상태
고체
색상
흰색에서 황백색까지

화학 및 산업

약리 정보

Mechanism of Action · 1건

Bisphosphonates are taken into the bone where they bind to hydroxyapatite. Bone resorption by osteoclasts causes local acidification, releasing the bisphosphonate, which is taken into the osteoclast by fluid-phase endocytosis. Endocytic vesicles become acidified, releasing bisphosphonates into the cytosol of osteoclasts where they act. Osteoclasts mediate resorption of bone. When osteoclasts bind to bone they form podosomes, ring structures of F-actin. Disruption of the podosomes causes osteoclasts to detach from bones, preventing bone resorption. Nitrogen containing bisphosphonates such as incandronate are known to induce apoptosis of hematopoietic tumor cells by inhibiting the components of the mevalonate pathway farnesyl diphosphate synthase, farnesyl diphosphate, and geranylgeranyl diphosphate. These components are essential for post-translational prenylation of GTP-binding proteins like Rap1. The lack of prenylation of these proteins interferes with their function, and in the case of Rap1, leads to apoptosis. incadronate also activated caspases 3, 4, and 7; further contributing to apoptosis.

Biological Half-LifeIncadronate has a biexponential half life. The T<sub>1/2</sub>α is 0.26-0.40h and the T<sub>1/2</sub>β is 1.58-1.98h.
Metabolism/MetabolitesIncadronate is not metabolized in rats.
Absorption, Distribution and ExcretionIncadronate is 55.1-69.5% eliminated in the urine as the unchanged parent drug.
응용 분야 · 2건

개요Bisphonal, a new third generation drug, was launched in Japan for the treatment of osteoporosis. It can be prepared in two steps by heating cycloheptylamine, triethylorthoformate and diethyl phosphite followed by ester hydrolysis. The mechanism of action is not well understood. Bisphonal has no effect on bone mineralization but tightly binds to calcified bone matrix and inhibits bone resorption. It causes a decrease in the number and activity of osteoclasts (morphology and decrease in H+ secretion). They seem to undergo cell death with an impairment in the process of osteoclast formation. Bisphonal does not induce osteomalacia and its activity is partly mediated through osteoblasts (releases an inhibitor of osteoclast recruitment). It is a potent inhibitor of squalene synthase (50-fold) maybe by Mg2+ chelation or as a pyrophosphate mimic, undergoes practically no metabolism, and stimulates renal production of 1,25-dihydroxyvitamin D.

관련 반응

3건
반응 기록 만들기
HRID 1073687 반응식
HRID 1073687생성물로uspto-grants-1990_11
HRID 2107344 반응식
HRID 2107344생성물로uspto-grants-1990_06
HRID 2248551 반응식
HRID 2248551생성물로uspto-grants-1991_08

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
Nikkaji
J615.831E

용도Incandronate is a bisphosphonate derivative. Bisphosphonates are most widely used as agents for treating osteoporosis and have also been used for other purposes such as herbicides, anticancer agents, and antiparasitics.

공급사12 곳

武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
台州南峰药物研究所[email protected] 13127117265 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
北京佰康和诺科技有限公司010-57296878 15633144420 · [email protected]
江苏艾康生物医药研发有限公司025-58851090 13913916777 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
广州优南科技有限公司020-82000279 18988941452 · [email protected]